Is There a Drug-Drug Interaction Between Darunavir/Ritonavir and Raltegravir?Fabbiani, M.Navarra, P.Cauda, R.De Luca, A.Di Giambenedetto, S.JAIDS -HAGERSTOWN MD-
Is There a Role for Therapeutic Drug Monitoring of Vitamin D Level as a Surrogate Marker for Fracture Risk? Clinical studies have suggested a possible association of low serum vitamin D levels in patients with bone fractures. This, coupled with a high prevalence ... JE Isenor,MHH Ensom - 《...
there is no drug-drug interaction between cerivastatin and nifedipinedoi:10.2165/00128415-199807150-00009NoneSpringer International PublishingReactions WeeklySachse R, Brendel E, Mück W, et al. No drug-drug interaction between cerivastatin and nifedipine. Naunyn-Schmiedebergs Arch Pharmacol 1998; 357 ...
摘要: there is no drug-drug interaction between cerivastatin and nifedipine 关键词:Public Health Oral Dose Nifedipine Clinical Pharmacology Crossover Study DOI: 10.2165/00128415-199807150-00009 被引量: 11 年份: 1998 收藏 引用 批量引用 报错 分享 ...
aAlthough it appears that a pharmacokinetic drug-drug interaction (DDI) was not demonstrated between docetaxel and plinabulin via apreliminary cross-study comparison, FDA will make the determination whether further evaluation is necessary after receiving the final study report. 虽然看起来约物动力学的药物...
Drug–drug interaction between isavuconazole and tacrolimus: a case report indicating the need for tacrolimus drug‐level monitoring Summary What is known and objective Despite the known significant drug鈥揹rug interaction between isavuconazole and tacrolimus, there are no recommendation... T Kim,T ...
To ascertain whether or not there exists a preference for certain residues at certain positions in the peptide sequence, an enrichment-depletion logo plot was created (Fig.4) for the hemolytic peptide class, with the non-hemolytic peptide class serving as the baseline for the plot. Enriched resi...
there is a time delay in both the onset and the offset relative to starting and stopping the inducing agent. Therefore, the full effect of the inducer may not be evident for several weeks after the inducer drug has been started. The resulting effect will take a similar period of time to ...
Palonosetron is a 5-HT3-receptor antagonist (serotonine antagonist) and is used in treatmentof metabolised by nonmicrosomal hydrolytic esterases in liver and other tissues [8] . CytochromeP450 enzymes is not MPH does not inhibit CYP 1A2, 2C8, 2C9, 2C19, 2D6 or 3A [7D Dideriksen...
前药Prodrug:Metabolism often results in inactivation of the drug. Some drug which were activated by metabolism. 首过效应First pass effect:Drugs that are absorbed from the gastrointestinal tract into the bloodstream go first to the liver via the portal vein. Once there,they may be metabolized so...